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The aim of this study was to identify changes of sleep spindles (SS) in the EEG of patients
with Parkinson’s disease (PD). Five sleep experts manually identified SS at a central
scalp location (C3-A2) in 15 PD and 15 age- and sex-matched control subjects. Each
SS was given a confidence score, and by using a group consensus rule, 901 SS were
identified and characterized by their (1) duration, (2) oscillation frequency, (3) maximum
peak-to-peak amplitude, (4) percent-to-peak amplitude, and (5) density. Between-group
comparisons were made for all SS characteristics computed, and significant changes for
PD patients vs. control subjects were found for duration, oscillation frequency, maximum
peak-to-peak amplitude and density. Specifically, SS density was lower, duration was
longer, oscillation frequency slower and maximum peak-to-peak amplitude higher in
patients vs. controls. We also computed inter-expert reliability in SS scoring and found a
significantly lower reliability in scoring definite SS in patients when compared to controls.
How neurodegeneration in PD could influence SS characteristics is discussed. We also
note that the SS morphological changes observed here may affect automatic detection
of SS in patients with PD or other neurodegenerative disorders (NDDs).
Keywords: Parkinson’s disease, sleep spindle morphology, EEG, neurodegeneration, biomarker
Introduction
Parkinson’s disease (PD) is a neurodegenerative disorder (NDD) characterized primarily by motor
symptoms, including bradykinesia, rigidity, postural instability, and tremor. Although the disease
process in PD is not restricted to a specific brain area, these symptoms are mostly caused by the
loss of dopaminergic neurons in the substantia nigra pars compacta resulting in a reduction or
depletion of dopamine (Galvin et al., 2001). Lewy body aggregations of alpha-synuclein in the
brain are a central feature of PD pathology (Galvin et al., 2001). These inclusions typically start
in caudal areas of the brain and progress anteriorly (Braak et al., 2003), and may take place years
prior to involvement of the substantia nigra and associated development of motor symptoms.
Abbreviations: AASM, American Academy of Sleep Medicine; EEG, electroencephalography; iRBD, idiopathic REM sleep
behavior disorder; MSA, Multiple System Atrophy; NDD, Neurodegenerative disorders; PD, Parkinson’s disease; PSG,
polysomnographic; REM, Rapid eye movements; SS, Sleep spindles.
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Specifically, Braak et al.’s PD staging is based on Lewy-body
distribution, which rise from the dorsal motor nucleus of the
vague nerve in the medulla and in the olfactory bulb (stage
1) emerging through the subceruleus-ceruleus complex and
the magnocellularis reticular nucleus (stage 2), the substantia
nigra, the pedenculopontine nucleus and the amygdala (stage
3), the temporal mesocortex (stage 4), and finally reaching the
neocortex (stage 5 and 6). Stage 1 and 2 were considered as pre-
Parkinsonian states, stage 3 and 4 as Parkinsonian states and 5
and 6 as late-Parkinsonian states (Braak et al., 2003).
In addition to the motor manifestations that define PD, non-
motor symptoms such as sleep problems, depression, dementia
and attention deficit (Chaudhuri et al., 2011, 2006), autonomic
symptoms as abnormal heart rate variability (Sorensen et al.,
2012, 2013) and gastrointestinal symptoms such as nausea and
constipation (Garcia-Ruiz et al., 2014) are all well known in
patients with PD. Stating the presence of at least two of the
four motor symptoms resting tremor, bradykinesia, rigidity, and
postural imbalance typically makes the clinical diagnosis of PD,
although it has been indicated that the pathological changes in
the striatal dopaminergic system develop several years before the
clinical appearance of PD. Further development of the pathology
may result in Lewy Body Dementia.
Twenty years ago, it was discovered that idiopathic rapid
eye movement (REM) sleep behavior disorder (iRBD) is closely
related to Parkinsonism (Schenck et al., 1996, 2013a; Salawu et al.,
2010). Indeed, the presence of iRBD, even without the presence
of motor or cognitive complaints, confers a significant risk of
conversion into synnucleinopathies including PD (Iranzo, 2011;
Schenck et al., 2013b). The diagnosis of RBD requires complaints
or an anamnesis describing dream enactment behaviors as well
as a manifestation of REM sleep without atonia (RSWA) as
measured by polysomnography (PSG) (Stevens and Comella,
2013; American Academy of Sleep Medicine, 2014). The
idiopathic form of RBD (iRBD) is diagnosed when no concurrent
neurological disease is found, and International classification of
Sleep Disorders criteria for RBD are met (Stevens and Comella,
2013; American Academy of Sleep Medicine, 2014). Specifically,
measures of RSWA (Postuma et al., 2010; Kempfner et al.,
2013), slow wave characteristics (Latreille et al., 2011), sleep
stability and differences in electroencephalographic (EEG) or
electrooculographic micro- and macro-sleep patterns have been
investigated in patients with iRBD and/or PD (Christensen et al.,
2012, 2013, 2014b).
Reduced sleep spindle (SS) density and activity have been
identified in patients with PD and iRBD (Puca et al., 1973;
Myslobodsky et al., 1982; Emser et al., 1988; Comella et al., 1993;
Christensen et al., 2014a; Latreille et al., 2015). SS are generated
by a complex interaction involving thalamic, limbic, and cortical
areas. A di-synaptic circuit between thalamic reticular neurons
and thalamocortical relay cells, both located in the thalamus,
can spontaneously generate spindle-like oscillations, which are
conveyed to the cortex by the axons of the thalamocortical relay
cells. These cells receive feedback from cortical pyramidal cells
as well as input from pre-thalamic fibers originating from the
brainstem and posterior hypothalamus (Steriade et al., 1993;
Steriade and Timofeev, 2003). As such the thalamus holds a
primary role in generating and controlling SS. SS have been
reported to have a gating role with regard to the flow of thalamic
sensory input, and thus may have a sleep-preserving role (De
Gennaro and Ferrara, 2003). Also, several studies have reported
SS to have an important role in memory consolidation, synaptic
plasticity and cognition (Steriade and Timofeev, 2003; Schabus
et al., 2006; Fogel and Smith, 2011; Fogel et al., 2012; Latreille
et al., 2015). The formation of SS begins in the infant brain (De
Gennaro and Ferrara, 2003), but SS characteristics such as density
and amplitude change with age (Nicolas et al., 2001; De Gennaro
and Ferrara, 2003), suggesting that SS play an important role in
normal cognitive functioning.
Although a reduction in SS density is not specific to PD, SS
and other EEG features may be potential useful as biomarkers
of disease progression or therapeutic efficacy in PD and other
NDDs (Nguyen et al., 2010; Leiser et al., 2011; Micanovic and Pal,
2014). However, the identification of SS is a difficult task; studies
assessing inter-scorer variance in normal sleep have shown
significant variance in SS identification, both between human
experts and between automated SS detectors (Warby et al., 2014;
Wendt et al., 2014). SS identification and characterization in
pathological sleep is not well studied, but previous evidence
suggests that SS may have different characteristics in PD
patients (Latreille et al., 2015), and therefore may interfere with
traditional sleep staging in patients (Comella et al., 1993; Jensen
et al., 2010; Christensen et al., 2014b; Koch et al., 2014).
In this study, we aimed to identify changes in SS density and
specific morphological characteristics of SS in patients with PD.
Since five sleep experts identified SS independently, we were also
able to assess inter-expert variation of SS identification in EEG
of patients and controls. By identifying specific changes in SS
characteristics, we aimed to better understand the mechanism
and to what extent the neurodegenerative progress influences SS
characteristics, also identifying specific spindle features that may
be useful as prognostic biomarkers of disease. A secondary aim
was to help guide the specialized development of automatic SS
detectors to be used on EEG from patients with NDDs.
Materials and Methods
Subjects and Recordings
Polysomnographic (PSG) EEG data from 15 patients with
PD and 15 sex- and age-matched control subjects with no
history of movement disorder, dream-enacting behavior or other
previously diagnosed sleep disorders were included in this
study. The subjects were all recruited from the Danish Center
for Sleep Medicine (DCSM) in the Department of Clinical
Neurophysiology, Glostrup University Hospital in Denmark.
All patients were evaluated by a movement specialist with
a comprehensive medical and medication history and a PSG
analyzed according to the American Academy of Sleep Medicine
(AASM) standard (Iber et al., 2007). The diagnostic certainty
for PD at Danish neurological departments has been reported
to be 82% (Wermuth et al., 2012). None of the PD patients had
dementia at inclusion, but one of the patients with PD later
developed Multiple System Atrophy (MSA), indicated as the
Parkinsonian type (MSA-P) as the patient had predominating
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PD-like symptoms. Subjects were excluded from the study if they
were taking medications known to effect sleep (antidepressants,
antipsychotics, hypnotics). However, dopaminergic treatments
were permitted despite their potential effect on vigilance and SS
characteristics (Puca et al., 1973; Micallef et al., 2009). In addition
to ethical concerns regarding discontinuing dopaminergic
treatment in these subjects, we wanted to avoid deleterious
discontinuation effects on the PSG, as well as unpleasant and
negative motor effects that could interfere with the study. The
quality of each PSG recording was individually examined, and
recordings with disconnections or significant amounts of signal
artifact were not included. Demographic data and PSG variables
for the two groups are seen in Table 1.
Manual Labeling of Sleep Spindles
For each subject, eight blocks of five consecutive epochs of non-
REM sleep stage 2 (N2) of 30-s duration were selected randomly
from the PSG recording in between lights off and lights on. The
blocks were randomly chosen and ranked by use of Matlab’s
randsample-function. One-by-one and in the prioritized order,
the blocks were visually checked for major movements or other
contaminating artifacts. The first eight artifact-free blocks were
chosen as the ones to be scored for SS. A total of five independent
sleep experts identified SS in these blocks, where only the C3-
A2 EEG derivation was visible. The signals were filtered with a
notch filter at 50Hz and a band-pass filter with cutoff frequencies
at 0.3Hz and 35Hz, as indicated by AASM standards (Iber
et al., 2007). All analyzed signals had a sampling frequency of
256Hz. The experts assigned a confidence score to each identified
spindle, to indicate the amount of confidence in the identification
(as described previously in Warby et al., 2014). In this way, each
SS was given a confidence weighting of 1 for “definitely SS,” 0.75
for “probably a SS” and 0.5 for “maybe a SS.”
The scoring procedure was performed in a Matlab-based
software program “EEG viewer” developed byMN at DCSM. The
program mimics a standard sleep scoring program in a clinical
TABLE 1 | Demographic and PSG data for the two groups studied.
Characteristics PD patients Controls P
Total counts (Male/Female) 15 (7/8) 15 (7/8) –
Age (Years) 62.7 ± 5.8 62.9 ± 5.9 0.90
BMI (kg/m2) 25.3 ± 3.5 22.1 ± 2.5 0.02
Disease duration (years) 6.7 ± 4.5 NA –
Hoehn and Yahr stage 2.0 ± 1.2 NA –
UPDRS part III “on” 20.9 ± 7.0 NA –
ACE 90.2 ± 4.8 NA –
Levodopa equivalent dosage (mg) 621.1 ± 301.5 NA –
Levodopa use [n ( %)] 10 (67) NA –
Dopamine agonist use [n (%)] 14 (93) NA –
Sleep efficiency (%) 79.7 ± 14.1 87.1 ± 8.4 0.09
Time in bed (min) 448.1 ± 82.0 499.6 ± 63.7 0.07
LM index (number/hour) 31.8 ± 34.8 30.4 ± 35.3 0.91
BMI, Body Mass Index; UPDRS, Unified Parkinson’s disease rating scale; ACE,
Addenbrooke’s cognitive examination; LM, Leg movements.
setting, and includes the standard features so the experts have the
same opportunities to view and navigate the PSG data as they are
used to when analyzing sleep in the clinic. The program ensures
that if an epoch to be scored does not have any marked SS, the
expert is required to click a box saying “no spindles in current
epoch.” This ensures that the total of 40 epochs of N2 sleep per
subject was analyzed by each expert. The experts were blinded for
which group the subjects belong to.
The final SS identifications used for morphology measures
were defined using the group consensus rule described in Warby
et al. (2014). Spindle identifications from five different experts
with weighted confidence scores for each SS were averaged at
each sample point and aggregated into a single consensus. Sample
points that had an average score of higher than the group
consensus threshold Tgc = 0.25 were included in the final group
consensus, and the morphology measures were computed on
these group consensus SS. It was decided to use Tgc = 0.25 as
this was found to be the best in Warby et al. (2014).
Spindle Characteristics and between Group
Comparisons
The morphology of the identified SS was characterized by
their (1) duration, (2) oscillation frequency, (3) maximum
peak-to-peak amplitude, (4) percent-to-peak amplitude, and
(5) SS density per minute; all of which are well-evaluated
elsewhere (Warby et al., 2014). The morphology measures were
all computed using Matlab 2013b. Before any of the measures
were computed, the central EEG signal was filtered forward
and reverse with (1) a notching filter with the notch at 50Hz
and a bandwidth of 50/35Hz (at −3 dB) and (2) a 4th order
Butterworth band-pass filter with cut off frequencies (−3 dB) at
0.3Hz and 35Hz.
For each SS the duration was computed in seconds as
dur =
# samples
fs
,
where fs = 256Hz is the sampling frequency and # samples
defines the number of samples. The samples were consecutive
and obeyed the consensus rule. The oscillation frequency was
defined in Hz and was for each SS estimated as
fosc =
K
2 · dur
,
where K defines the total number of extrema points detected
using Matlab’s findpeaks-function applied on a 5-point moving
average smoothed version of the SS signal and with a minimum
peak-to-peak distance of 11 samples. The maximum points
were found by applying the findpeaks-function directly, and the
minima points were found by applying the function on the
flipped signal, and the total number of extrema points was set
as the sum of the two. These settings were chosen, as they were
considered best for estimating the fosc when visually investigating
numerous randomly selected examples of SS. The maximum
peak-to-peak amplitude was for each SS estimated as
Ap2p = max
(∣∣Ae (k + 1)− Ae(k)∣∣) , k = 1, 2, . . . ,K − 1,
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where Ae is a vector holding the amplitude values for each of
the K detected extrema points. To investigate the influence on
SS from K-complexes or delta waves, the maximum peak-to-
peak amplitude was estimated twice for each SS; once without
any further frequency filtering of the data, and once where the
data was forward and reverse filtered with a 10th order high-
pass filter with cut off frequency (−3 dB) at 4Hz to remove low
frequency, high amplitude waves that may interfere with the
peak-to-peak calculation. The percent-to-peak amplitude gives a
simple measure between 0 and 1 of the symmetry of the spindle
and it was computed for each SS as
Sym =
# samples before point of Ap2p
# samples
,
where the point of Ap2p is defined as the point between the
maxima and minima delineating Ap2p. Finally, the density was
computed for each subject as the number of SS per minute of
investigated data, described as
Density =
2 · # SS
# epochs reviewed
.
The morphology measures were computed for the SS
identifications for each expert, as well as for the spindles
included in the group consensus. For the SS included in the
group consensus, a minimum duration threshold durth = 0.2 s
was used, and resulted in the exclusion of only three spindles.
This threshold is less that the minimum duration stated by the
AASM scoring (0.5 s). However, others have shown that apparent
spindles <0.5 s are clearly recognizable by sleep experts, and
have similar characteristics to spindles >0.5 s (Warby et al.,
2014). We used a minimum duration threshold of 0.2 s because
we wanted to determine whether PD patients and controls have
specific differences in these shorter spindles. When computing
the measures for the SS identifications for each expert, all the SS
were included, regardless of their confidence score and duration.
Two-sided Wilcoxon rank sum tests with a significance level of
α = 0.05 were used for each of the measures to test for significant
differences between the two groups.
Inter-Expert Reliability When Scoring SS
Inter-expert reliability measures were computed for each of the
10 available expert-pairs. True positives (TP) define the number
of samples where both experts have marked SS, true negatives
(TN) define the number of samples where both experts have not
marked SS, false positives (FP) define the number of samples
where the reference-expert has not marked SS, and the other
expert has and false negatives (FN) define the number of samples
where the reference-expert has marked SS, but the other expert
has not. For each comparison, the reliability measures were
indicated as the F1-score and the Cohen’s Kappa coefficient (κ).
The F1-score is the harmonic mean of precision (P) and recall (R)
and reaches its best value at 1 (perfect agreement) and the worst
at 0 (no agreement). It is computed as
F1-score =
2 · R · P
R+ P
,where
R =
TP
TP + FN
and P =
TP
TP + FP
.
The κ is often used to measure inter-annotator reliability as
it takes the agreement occurring by chance into account. It
reached its best value at 1 (perfect agreement) and worst at -1
(no agreement). It reaches 0 when accuracy is equal to what is
expected by chance. It is computed as
κ =
TP+TN
N − Pr
1− Pr
,where
Pr =
TP + FN
N
·
TP + FP
N
+(
1−
TP + FN
N
)
·
(
1−
TP + FP
N
)
,
where N = TP + TN + FP + FN defines the total number of
samples reviewed. The relative strength of agreement associated
with κ can been described by the labels “poor” (κ <0.00), “slight”
(0.00 ≤ κ ≤ 0.20), “fair” (0.21 ≤ κ ≤ 0.40), “moderate”
(0.41 ≤ κ ≤ 0.60), “substantial” (0.61 ≤ κ ≤ 0.80) and “almost
perfect” (0.81 ≤ κ ≤ 1.00) (Landis and Koch, 1977). The F1-
score and κ are symmetric regarding false detections and will
therefore both yield the same regardless of which expert were
used as the reference.
Results
For the SS included in the group consensus, it was found
that patients with PD show SS that are significantly different
from controls in terms of duration, oscillation frequency and
max peak-to-peak amplitude. Additionally, patients with PD
have significantly different SS density compared to controls.
Specifically, it was found that patients with PD have decreased
SS density (−38.17%/−0.71 SS/min), and that their SS are longer
(+11.69%/+0.09 s), have a lower frequency (−2.27%/−0.29Hz)
and higher max peak-to-peak amplitude (+19.61%/9.45µV)
compared to controls (Table 2). No significant differences were
identified for the symmetry measure. The maximum peak-to-
peak amplitude estimated after removal of frequencies below
4Hz was still significantly different between groups. Of note,
patients with PD still showed a higher max peak-to-peak
amplitude (+20.95%/9.49µV) compared to controls. The five
SS morphology measures are illustrated in Figure 1. From left
to right, the eight first ID numbers in both groups are females
ranging from the youngest to the oldest. The last seven IDs in
both groups are males, also ranging from the youngest to the
oldest. One of the patients later developed MSA and is illustrated
with black.
The patients had significantly fewer spindles than the controls
(p-value < 0.05). Ten patients and only four controls had less
than 10 SS in the 40 epochs of N2 sleep that were assessed; four
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patients and 0 controls had no SS. Only 3 patients compared to
10 controls had more than 20 SS in the group consensus.
As a supplementary check, the significance tests were
performed on SS identifications from each of the five experts
individually. The maximum peak-to-peak amplitude was, for
all five experts, both before and after removal of frequencies
below 4Hz, significantly different in patients with PD compared
to controls. The duration and oscillation frequency were also
significantly different between the two groups for 4/5 of the
experts, and density significantly different between the two
groups for 3/5 of the experts. The mean and standard deviations
of the SS morphology measures and the results from the
significance tests are summarized in Table 2.
Figure 2 illustrates the relation between the SS measures and
disease duration for the patients, and Figure 3 illustrates the
relation between the SS measures and Addenbrooke’s Cognitive
Examination (ACE) score for the patients. Note that the x-
axes are not continuous, but denote disease duration in years
(Figure 2) and ACE score (Figure 3) for 15/15 and 13/15
of the patients, respectively. The three subjects with highest
SS density are all females, and the one with the highest
SS density is a patient with PD later diagnosed with MSA-
P (indicated as PD+MSA in the figures). She is illustrated
with black in Figures 1, 2, 3. No clear visual tendency
between SS characteristics and disease duration or ACE score
was seen for any of the measures. Supplementary Figure 1
illustrates the relation between SS measures and Hoehn and
Yahr (H and Y) stage and Supplementary Figure 2 illustrates
the relation between SS measures and the Unified Parkinson’s
Disease Rating Scale (UPDRS) Part III. No clear visual trends
were seen.
Considering that the outlier PD patient with a very high
spindle density (highest of all subjects in the study) later
developed MSA, we reanalyzed the SS included in the group
consensus when results from this outlier patient were left out,
and found the same measures to be as significant different
between the groups. Specifically, patients now have an even
bigger decrease in SS density (−61.29%/−1.14 SS/min), a
longer SS duration (+11.69%/+0.09 s), a slower frequency
(−4.14%/−0.53Hz) and a higher max peak-to-peak amplitude,
both before (+16.93%/8.16µV) and after (+17.95%/8.13µV)
removal of low frequencies when compared to controls. The
results for this analysis are summarized in Table 3.
Figure 4 shows scatterplots for the individual SS, where
the maximum peak-to-peak amplitude (before removal of low
frequencies) defines the y-axis and the oscillation frequency and
duration defines the x-axis, respectfully. Linear trend lines are
added on top of the scatterplots in order to see differences
between groups. We found a trend of a positive correlation
between the duration and maximum peak-to-peak amplitude.
Interestingly, SS from patients showed this tendency to a lesser
degree (slope of +11.74µV/s) compared to SS from controls
(slope of +18.09µV/s). Also, we found a negative correlation
of oscillation frequency and maximum peak-to-peak amplitude,
and found this tendency to be less apparent for SS from
patients (slope of −1.02µV/Hz) compared to SS from controls
(slope of−4.10µV/Hz).
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FIGURE 1 | Distributions of the morphology measures for the
spindles included in the group consensus. From left to right, the
first eight IDs in both groups are females ranging from the youngest
to the oldest, and the following seven IDs are males also ranging
from the youngest to the oldest. One patient with Parkinson’s disease
(PD) later developed Multiple System Atrophy (MSA) and is indicated
with black. The cyan horizontal lines indicate the group median for
each of the measures.
Table 4 summarizes the fraction of SS included in the group
consensus that do not strictly pass AASM criteria for a spindle
(11–16Hz, 0.5–3.0 s). Overall, 25.3% of the SS identified by
experts and included in the group consensus did not meet AASM
criteria. Most of these “abnormal” SS would have been excluded
because their duration is too short (16.9%) or have an oscillation
frequency that is too slow (9.7%).
In order to determine if there was a difference between
PD and controls in the frequency of “abnormal” spindles not
meeting AASM criteria, we compared the groups. All 15/15
control subjects had SS, whereas only 11/15 patients with PD had
some SS. It was found that control subjects show significantly
more “abnormal” spindles not meeting AASM criteria, i.e., more
spindles with a too short duration compared to patients with PD
(Table 4). No significant difference was however found between
groups when the outlier patient with PD + MSA was left out of
the analysis.
When computing the SS characteristic based on AASM
criteria, the same SS characteristics were found to be significantly
different between PD patients and controls (Table 5). Analysis
of these SS showed that patients with PD have a decreased
density (−32.84%/−0.44 SS/min), and their SS are longer
(+9.41%/+0.08 s), have a lower frequency (−2.69%/−0.35Hz)
and higher max peak-to-peak amplitude before removal of low
frequencies (+21.34%/+10.37µV) and after (+22.51%/+10.30)
compared to controls. These differences are similar to those
found based on all SS in the group consensus.
Table 6 summarizes inter-expert reliabilities of SS scoring,
where the SS are grouped according to their confidence
score. The mean inter-expert reliability of scoring “definite SS”
computed by κ was found to be significant lower for patients
compared to controls. Although not significant, a trend for
a lower κ was found for “probable/definite SS” in patients
compared to controls (P = 0.054). In all cases, the inter-expert
reliability is lower for scoring SS in patients compared to controls.
Discussion
Based on a group consensus of manually scored SS from five
independent sleep experts, this study investigates morphological
changes of SS in a central EEG lead of patients with PD compared
to age- and sex-matched control subjects. The main findings of
this study are that patients with PD have a decreased SS density,
and that their SS have a longer duration, a slower oscillation
Frontiers in Human Neuroscience | www.frontiersin.org 6 May 2015 | Volume 9 | Article 233
Christensen et al. Spindle alterations in PD patients
FIGURE 2 | Distribution of the morphology measures for the spindles from patients with Parkinson’s disease (PD), where the patients are sorted
according to their disease duration. PD+MSA indicates a patient with PD, that later developed Multiple System Atrophy (MSA).
frequency and higher maximum peak-to-peak amplitude. These
results suggest that not only SS density but also specific
morphological changes in SS have potential clinical utility when
diagnosing PD. Further, the data suggests that the disease process
affect directly or indirectly the brain regions responsible for
the generation of SS. Future studies including more subtypes
of PD and NDDs in general are however needed to investigate
whether the specific morphological changes in SS can be used to
differentiate different PD subtypes as well as different NDDs.
The results illustrate the fact that there are fewer SS in
patients with PD, and that the few that are remaining are more
pronounced when compared to those seen in controls. There
could be several explanations for this. First, patients with PD
have a more “blurred” EEG in general with either a lack of or
an abnormal mixture of micro- and macro-sleep structures (Petit
et al., 2004; Christensen et al., 2014b). This pattern may make
it more difficult to identify distinct SS, as they would be buried
within other undefined EEG microstructural changes. In this
case, only the obvious SS would rise over background and be
marked. Second, it could be that the neurodegenerative process
has affected the thalamic neurons responsible for generating
and controlling SS in such a way, that SS are only generated
when very strong signals from pre-thalamic fibers reaches the
thalamus resulting in more pronounced SS. Third, we cannot
rule out that these SS changes could be the result of treatment
with dopaminergic agents affecting the morphology of SS,
although a previous report suggests that these drugs should
increase spindle density (Puca et al., 1973), which is not what
we observed.
It was found that patients with PD have a lower SS density
compared to age and sex-matched controls. This finding is
consistent with our and other groups’ prior findings (Emser
et al., 1988; Christensen et al., 2014a; Latreille et al., 2015), but
contradicts those of other studies (Happe et al., 2004). According
to Braak et al. (2003), the neurodegenarative progress in PD
shows a progressive ascending course starting from the brain
stem and spreading to additional brain structures. At some point,
the neurodegeneration may affect or destroy the SS generator
of the thalamus, resulting in fewer or no spindles. Interestingly,
(Roth et al., 2000) found that medial thalamotomy abolishes
spindle activity in N2 sleep systematically, but that pallido-
thalamic tractotomy attenuate spindle activity only to a varying
degree, with spindles reemerging after 3 months. It is therefore
likely that neurodegenerative involvement of prethalamic fibers
from the brain stemmay affect spindle activity to a certain degree.
In Figure 1, it is apparent that for four of the patients, no SS are
included in the group consensus, and that for six other patients,
less than 10 spindles were identified.
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Surprisingly, a PD patient showing an abnormally high SS
density was later diagnosed with MSA-P. Although only a single
case, it is an interesting finding which support the hypothesis that
spindles can be used as a marker of diagnostic subgroups of PD.
Latreille et al. (2015) reported a decline in SS activity paralleling
cognitive decline in patients with PD, suggesting that SS activity
could be used as an early marker of Dementia. The number
of patients included in present study is, however, too small to
perform further subgroup analysis. Additionally, in both groups,
younger subjects and females trend in showing slightly higher
spindle densities when compared to older and male subjects. The
three oldest male control subjects have negligible SS densities.
These observations suggest that reduced SS density is not specific
for PD, in agreement with the fact that many conditions such
as cognitive function, memory consolidation, pharmacological
interventions and pre-PSG conditions have been reported to
influence SS density (De Gennaro and Ferrara, 2003; Caporro
et al., 2012). Further analysis including more PD and iRBD
patients, together with a more in-depth investigation of cognitive
decline and disease severity would be needed to evaluate the
relation of abnormalities in SS development in the disease
process, and the use of SS as a prognostic marker. Additionally,
SS density has also been reported decreased for other conditions
such as Dementia, Alzheimer’s disease (AD) and mild cognitive
impairment (Rauchs et al., 2008; Westerberg et al., 2012; Latreille
et al., 2015), and is also a sign of normal aging (Wauquier, 1993;
De Gennaro and Ferrara, 2003; Ktonas et al., 2009).
To our knowledge, no studies have investigated the impact of
L-DOPA on SS morphology. Previous studies have reported that
TABLE 3 | Mean (µ) and standard deviation (σ) for characteristics of
spindles in patients with Parkinson’s disease (PD) compared to
controls (C).
Spindle characteristic Group consensus (759SS) P
PD(-MSA) C
Duration [sec, µ ± σ] 0.86 ± 0.35 0.77 ± 0.36 <0.001
Frequency [Hz, µ ± σ] 12.27 ± 1.07 12.80 ± 1.23 <0.001
Max peak-to-peak amplitude
[µV, µ ± σ]
56.35 ± 18.97 48.19 ± 15.55 <0.001
Max peak-to-peak amplitude
After removal of frequencies <
4Hz [µV, µ ± σ]
53.42 ± 17.84 45.29 ± 14.41 <0.001
Percent-to-peak amplitude
[µ ± σ]
0.47 ± 0.23 0.46 ± 0.23 NS
Density [per min, µ ± σ] 0.72 ± 1.28 1.86 ± 1.57 <0.007
In this case, the patient that later was diagnosed with Multiple System Atrophy (MSA)
was excluded from the PD group [PD (-MSA)]. P-values for the Wilcoxon rank sum tests
between the two groups are shown. Only spindles in the group consensus are included
in the comparison.
FIGURE 3 | Distribution of the morphology measures for the
spindles from 13/15 patients with Parkinson’s disease (PD),
where the patients are sorted according to their
Addenbrookse’s cognitive examination (ACE) scores. PD +
MSA indicates a patient with PD, that later developed Multiple
System Atrophy (MSA).
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SS density is increased in patients with PD taking dopaminergic
treatment compared to non-treated patients, but the study
lacks a comparison to controls, and evaluation of spindle
morphology (Puca et al., 1973). As dopaminergic treatments
were not discontinued in this study, we cannot rule out that the
changes in SS morphology observed are due to the dopaminergic
interactions from the treatments, although we do not believe so,
as we did not see increases in SS density in these subjects. Future
studies will have to investigate this further including a potential
association between amount and duration of L-DOPA and/or
dopamine agonist treatment and SS morphological changes.
Surprisingly, SS in patients with PD had a longer duration and
a higher maximum peak-to-peak amplitude. To our knowledge,
no other studies have reported differences in SS duration in
patients with PD when compared to controls. The maximum
peak-to-peak amplitude significantly differ for SS identifications
in the group consensus as well as for each of the individual
expert’s identifications. This finding was also significant after we
FIGURE 4 | Two scatterplots for individual SS characteristics. The plot illustrates the maximum peak-to-peak amplitude (without removal of frequencies below
4Hz) as a function of (1) duration (top plot) and (2) oscillation frequency (lower plot), respectively. Trend lines are added for each group.
TABLE 4 | Percent of sleep spindles (SS) identified in the group consensus that do not strictly meet AASM criteria Iber et al. (2007).
AASM criteria Total PD SS PD-MSA Control P-value P-value
SS SS SS PD vs. controls PD-MSA vs. controls
Duration too short (<0.5 s) 0.169 0.128 0.134 0.194 0.010 NS
Duration too long (>3 s) 0.001 0 0 0.002 NS NS
Oscillation frequency too slow (<11Hz) 0.097 0.090 0.099 0.101 NS NS
Oscillation frequency too high (>16Hz) 0.002 0.003 0.005 0.002 NS NS
At least one criteria not met 0.253 0.212 0.228 0.278 0.027 NS
There were a total of 344SS from 11 patients with Parkinson’s disease (PD) and 557SS from 15 control subjects. There were 202 SS from 10 patients when one patient with PD, who
later was diagnosed with Multiple System Atrophy (MSA) [PD(-MSA)] was left out. X2-tests were used to test for significance between spindles from PD patients (including and excluding
the one with MSA) and control subjects.
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filtered the data to eliminate the impact of low frequency, high
amplitude waves. This was surprising, and contradicts the idea
that polygraphic features such as SS and K-complexes are less well
formed in various NDDs (Petit et al., 2004; Ktonas et al., 2009).
By computing maximum peak-to-peak amplitude both without
any further filtration and after elimination of low frequencies, our
data show that patients with PD show SS with higher amplitudes,
regardless of the EEG patterns surrounding them. Margis et al.
(2015) reports increased sigma power in N2 sleep of patients
with PD vs. controls. Increased sigma power is consistent with
our findings of increased duration and amplitude of spindles,
which would overpower the decrease in spindle density we and
others have reported in PD. Interestingly, SS morphology was
unchanged in schizophrenia patients compared to controls, even
though they had a significant decrease in SS density (Wamsley
et al., 2012).
Enhanced maximum peak-to-peak amplitude is also not
consistent with the findings of Latreille et al. (2015), who reports
no significant differences of SS amplitude between PD patients
TABLE 5 | Mean (µ) and standard deviation (σ) for the spindle
characteristics found for the spindles in the group consensus meeting the
AASM criteria.
Spindle characteristic Group consensus (673SS) P
PD C
Duration [sec, µ ± σ] 0.93 ± 0.33 0.85 ± 0.31 1.95 .10−4
Frequency [Hz, µ ± σ] 12.65 ± 1.01 13.00 ± 0.96 9.04 .10−6
Max peak-to-peak amplitude
[µV, µ ± σ]
58.97 ± 16.64 48.60 ± 14.92 3.90 .10−16
Max peak-to-peak amplitude
After removal of frequencies <
4Hz [µV, µ ± σ]
56.06 ± 15.75 45.76 ± 13.89 5.27 .10−18
Percent-to-peak amplitude
[µ ± σ]
0.47 ± 0.23 0.45 ± 0.23 NS
Density [per min, µ ± σ] 0.90 ± 1.71 1.34 ± 1.25 4.50 .10−2
Wilcoxon rank sum tests were used to test for significance between patients with PD and
control subjects (C).
and controls, and significantly reduced SS amplitude in patients
with PD, who later developed Dementia when compared with
controls. The SS in Latreille et al. (2015) were found automatically
and mandated a duration criteria of least 0.5 s to be included.
Also, the spindle detection method includes a filtration of the
signal (11–15Hz) and a threshold determined based on root-
mean-square (RMS) values of the background NREM activity
(Martin et al., 2013). Lastly, the SS in Latreille et al. (2015) were
detected in all NREM stages, and the individual SS characteristics
(amplitude and frequency) were computed as the mean of
both hemispheres, as they found no significant hemispheric
interaction. The definition of SS is thus not the same in the two
studies, and the different results could be due to the fact that
automatic detectors detect SS that humans cannot see. Another
explanation could be that the detector in Latreille et al. (2015)
lack to identify the smaller SS in controls, thereby enlarging
the mean spindle amplitude in controls. If the threshold used is
based on values across all NREM sleep stages, different amount
of NREM stages between controls and patients influences the
threshold, maybe resulting in harder thresholds to cross for
control spindles. Lastly, taking into account the fact that PD
patients show more mixed sleep patterns making sleep stages
more difficult to distinguish (Danker-Hopfe et al., 2004; Jensen
et al., 2010), it could also be that more N3 sleep is present in the
annotated data of patients compared to controls, although we did
select data fromN2 sleep according to each hypnogram.Whether
the contradicting findings are due to methodological reasons
only, have to be investigated in future studies, e.g., by applying
different automatic spindle detectors on the same dataset and
on data from different derivations, and see if the morphological
alterations are consistent across detectors, manually scorings and
derivations.
EEG slowing has been frequently reported in PD (Petit
et al., 2004; Rodrigues Brazète et al., 2013), including slowing
in occipital, temporo-occipital and frontal regions (Sirakov and
Mezan, 1963; Soikkeli et al., 1991; Primavera and Novello, 1992).
It is therefore not surprising that we found slower SS oscillation
frequencies in PD patients. Whether or not this is specific for PD
or generalizable to other NDDs will need further investigations.
TABLE 6 | Mean (µ) and standard deviation (σ) for the inter-expert reliability measure F1-scores and Cohen’s Kappa (κ) for scoring sleep spindles (SS).
SS group definition F1-score κ P
PD C PD C
Low confidence “maybe” 0.12 ± 0.11 0.17 ± 0.12 0.14 ± 0.11
“slight”
0.16 ± 0.12
“slight”
NS
Medium confidence “probably” 0.13 ± 0.10 0.19 ± 0.11 0.15 ± 0.10
“slight”
0.18 ± 0.11
“slight”
NS
High confidence “definitely” 0.24 ± 0.13 0.32 ± 0.13 0.21 ± 0.13
“fair”
0.32 ± 0.13
“fair”
4.76 .10−2κ
Medium or high confidence “probably/definitely” 0.34 ± 0.15 0.39 ± 0.17 0.28 ± 0.15
“fair”
0.39 ± 0.17
“fair”
NS
All SS 0.41 ± 0.16 0.45 ± 0.15 0.32 ± 0.17
“fair”
0.43 ± 0.15
“moderate”
NS
The mean and standard deviations are taken across the ten expert-pairs available. Wilcoxon rank sum tests were used to test for significantly lower inter-expert reliability for scoring SS
in patients with Parkinson’s disease (PD) compared to control subjects (C). κ indicates significance for κ and F indicates significance for F1-score.
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In AD, Rauchs et al. (2008) found no change in spindle density
but found that fast spindles (defined as having frequencies of
13–15Hz) were significantly reduced when compared to age-
matched controls. Consistently, Westerberg et al. (2012) found
that patients with amnestic mild cognitive impairment had fewer
N2 spindles compared to age-matched controls, and that the
reduction was seen in fast spindles (13–15Hz) and not in slow
spindles (11–13Hz). Latreille et al. (2015) found significant lower
SS frequency in patients with PD who later developed Dementia
compared to controls, but not in Dementia-free patients with PD
compared to controls. This last study might however suffer from
a selection bias as they automatically defined SS within a certain
frequency range, as stated by the AASM. Nonetheless, as in this
study, we found that PD patients had a slower SS frequency, both
when looking at SS included in the group consensus, but also
when looking at SS strictly meeting AASM criteria.
Figures 2, 3 and Supplementary Figures 1, 2 report on SS
measures for the PD group consensus, but with subjects sorted
according to their disease duration (Figure 2), their ACE score
(Figure 3), their H and Y stage (Supplementary Figure 1) and
UPDRS part III score (Supplementary Figure 2). Although no
clear tendency was seen for any of the SS measures for disease
duration, ACE score, H and Y stage or UPDRS part III score,
longitudinal studies are likely needed to determine whether SS
morphology measures can provide prognostic value. Indeed,
the patients included here may have had a PD diagnosis
for various amounts of time, and inter-subject variation of
disease progression and severity makes such a relationship very
complicated to analyze. ACE is a brief assessment of cognitive
functions and is in this study used as a screening tool to
determine Dementia, which none of the patients had at inclusion.
A more in-depth examination of cognitive functions as well as
a follow-up study of the patients is needed to determine the
subject-specific progression and severity rate. These rates can
be compared to the SS morphology measures to investigate the
prognostic value.
A biomarker does not have to be specific to a disease to have
clinical utility, and combining the different SS measures may
reveal that different diseases show different trends or different
combinations of changes in SS morphology measures. If a trend
is found, it is important to also look at SS that might fall out of
the stated AASM criteria, as not doing that may misrepresent
the data. Table 4 shows that a rather high proportion of SS in
both groups do not meet AASM criteria. Additionally, when
looking at inter-expert reliability, it was found that experts are
less likely to agree on definite SS in patients when compared to
controls. Considering that automatic SS detectors are likely to
be used in patients with NDDs, it is highly encouraged to build
detectors capable of detecting atypical SS as well. Such atypical
SS could be spindles with abnormal duration or frequency or
spindles surrounded by EEG that is not typically seen in N2
sleep. Because of this, detectors should not be constrained or
designed to perform well only in the context of a single expert
or for normal EEG. Ideally, automatic detectors should give
a confidence score for each detected SS and group subtypes
of SS using specific parameters describing their morphology.
Specifically, description of “probable SS” in different patient
groups may give a better idea of the specific morphological
changes that can be observed for each disease. Also, such studies
should investigate how disease duration and/or severity impact
morphology. Such in-depth studies would be beneficial to better
understand the pathological differences between the NDDs and
also see if any of the morphology measures hold potential for
separating diseases or subtypes of them.
In conclusion, we investigated SS in an objective way and
found that the oscillation frequency and duration of SS manually
scored in clinical settings are not necessarily bound to the limits
given by AASM. The shorter or slower SS must have had an
ability to stand out from the background EEG, and we believe
that these per-definition-not-SS should be included in studies
analyzing SS morphology changes, particularly when searching
for disease biomarkers.
Based on a group consensus of five individual experts’
identification of SS in N2 sleep, we compared 15 patients
with PD with 15 age-matched control subjects and found that
patients show a lower SS density and that their SS have a
longer duration, a higher maximum peak-to-peak amplitude and
a slower oscillation frequency. All the included patients were
taking dopaminergic treatment, and we can therefore not rule out
that the significant differences found could be due to treatment
effects. We conclude that SS are significantly altered in patients
with PD, but that due to high inter-subject variability in disease
progression and severity, future longitudinal studies are needed
to investigate the clinical utility of the SS morphology changes as
well as their value as prognostic biomarkers.
Financial Support
The PhD project is supported by grants from H. Lundbeck A/S,
the Lundbeck Foundation, the Technical University of Denmark
and the Center for Healthy Aging, University of Copenhagen.
Acknowledgments
The authors would like to thank the five experts for their time
and effort in annotating and giving confidence scores of the sleep
spindles analyzed in this study. The PhD project is supported
by grants from H. Lundbeck A/S, the Lundbeck Foundation,
the Technical University of Denmark, Center for Healthy Aging,
University of Copenhagen and Stanford Center for Sleep Sciences
and Medicine.
Supplementary Material
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fnhum.
2015.00233/abstract
Supplementary Figure 1 | Distribution of the morphology measures for the
spindles from 11/15 patients with Parkinson’s disease (PD), where the
patients are sorted according to their Hoehn and Yahr (H and Y) stage.
Supplementary Figure 2 | Distribution of the morphology measures for the
spindles from 11/15 patients with Parkinson’s disease (PD), where the
patients are sorted according to their Unified Parkinson’s Disease Rating
Scale (UPDRS) part III score.
Frontiers in Human Neuroscience | www.frontiersin.org 11 May 2015 | Volume 9 | Article 233
Christensen et al. Spindle alterations in PD patients
References
American Academy of Sleep Medicine. (2014). International Classification of
Sleep Disorders - Third Edition (ICSD-3), 3rd Edn. Westchester, IL: American
Academy of Sleep Medicine.
Braak, H., Tredici, K., Del Rüb, U., Vos, R. A., de Steur, E. N. H. J., and Braak,
E. (2003). Staging of brain pathology related to sporadic Parkinson’s disease.
Neurobiol. Aging 24, 197–211. doi: 10.1016/S0197-4580(02)00065-9
Caporro, M., Haneef, Z., Yeh, H. J., Lenartowicz, A., Buttinelli, C., Parvizi, J., et al.
(2012). Functional MRI of sleep spindles and K-complexes. Clin. Neurophysiol.
123, 303–309. doi: 10.1016/j.clinph.2011.06.018
Chaudhuri, K. R., Healy, D. G., and Schapira, A. H. (2006). Non-motor symptoms
of Parkinson’s disease: diagnosis and management. Lancet Neurol. 5, 235–245.
doi: 10.1016/S1474-4422(06)70373-8
Chaudhuri, K. R., Odin, P., Antonini, A., and Martinez-Martin, P. (2011).
Parkinson’s disease: the non-motor issues. Parkinsonism Relat. Disord. 17,
717–723. doi: 10.1016/j.parkreldis.2011.02.018
Christensen, J. A. E., Frandsen, R., Kempfner, J., Arvastson, L., Christensen,
S. R., Jennum, P., et al. (2012). Separation of Parkinson’s patients in early
and mature stages from control subjects using one EOG channel. Conf.
Proc. IEEE Eng. Med. Biol. Soc. 2012, 2941–2944. doi: 10.1109/EMBC.2012.
6346580
Christensen, J. A. E., Kempfner, J., Zoetmulder, M., Leonthin, H. L., Arvastson, L.,
Christensen, S. R., et al. (2014a). Decreased sleep spindle density in patients
with idiopathic REM sleep behavior disorder and patients with Parkinson’s
disease. Clin. Neurophysiol. 125, 512–519. doi: 10.1016/j.clinph.2013.08.013
Christensen, J. A. E., Koch, H., Frandsen, R., Kempfner, J., Arvastson, L.,
Christensen, S. R., et al. (2013). Classification of iRBD and Parkinson’s patients
based on eye movements during sleep. Conf. Proc. IEEE Eng. Med. Biol. Soc.
2013, 441–444. doi: 10.1109/EMBC.2013.6609531
Christensen, J. A. E., Zoetmulder, M., Koch, H., Frandsen, R., Arvastson, L.,
Christensen, S. R., et al. (2014b). Data-driven modeling of sleep EEG and EOG
reveals characteristics indicative of pre-Parkinson’s and Parkinson’s disease.
J. Neurosci. Methods 235, 262–276. doi: 10.1016/j.jneumeth.2014.07.014
Comella, C. L., Tanner, C. M., and Ristanovic, R. K. (1993). Polysomnographic
sleep measures in Parkinson’s disease patients with treatment-induced
hallucinations. Ann. Neurol. 34, 710–714. doi: 10.1002/ana.410340514
Danker-Hopfe, H., Kunz, D., Gruber, G., Klösch, G., Lorenzo, J. L., Himanen, S.
L., et al. (2004). Interrater reliability between scorers from eight European sleep
laboratories in subjects with different sleep disorders. J. Sleep Res. 13, 63–69.
doi: 10.1046/j.1365-2869.2003.00375.x
De Gennaro, L., and Ferrara, M. (2003). Sleep spindles: an overview. Sleep Med.
Rev. 7, 423–440. doi: 10.1053/smrv.2002.0252
Emser,W., Brenner, M., Stober, T., and Schimrigk, K. (1988). Changes in nocturnal
sleep in Huntington’s and Parkinson’s disease. J. Neurol. 235, 177–179. doi:
10.1007/BF00314313
Fogel, S., Martin, N., Lafortune, M., Barakat, M., Debas, K., Laventure, S., et al.
(2012). NREM sleep oscillations and brain plasticity in aging. Front. Neurol.
3:176. doi: 10.3389/fneur.2012.00176
Fogel, S. M., and Smith, C. T. (2011). The function of the sleep spindle: a
physiological index of intelligence and a mechanism for sleep-dependent
memory consolidation. Neurosci. Biobehav. Rev. 35, 1154–1165. doi:
10.1016/j.neubiorev.2010.12.003
Galvin, J. E., Lee, M.-Y., and Trojanowski, J. Q. (2001). Synucleinopathies:
clinical and pathological implications. Arch. Neurol. 58, 186–190. doi:
10.1001/archneur.58.2.186
Garcia-Ruiz, P. J., Chaudhuri, K. R., and Martinez-Martin, P. (2014). Non-motor
symptoms of Parkinson’s disease A review. . . from the past. J. Neurol. Sci. 338,
30–33. doi: 10.1016/j.jns.2014.01.002
Happe, S., Anderer, P., Pirker, W., Klösch, G., Gruber, G., Saletu, B., et al. (2004).
Sleep microstructure and neurodegeneration as measured by [123I]beta-CIT
SPECT in treated patients with Parkinson’s disease. J. Neurol. 251, 1465–1471.
doi: 10.1007/s00415-004-0564-3
Iber, C., Ancoli-Israel, S., Chesson, A. L., and Quan, S. F. (2007). The AASM
Manual for the Scoring of Sleep and Associated Events: Rules, Terminology, and
Tchnical Specification. Westchester, IL: American Academy of Sleep Medicine.
Iranzo, A. (2011). Sleep-wake changes in the premotor stage of Parkinson disease.
J. Neurol. Sci. 310, 283–285. doi: 10.1016/j.jns.2011.07.049
Jensen, P. S., Sorensen, H. B. D., Leonthin, H. L., and Jennum, P. (2010). Automatic
sleep scoring in normals and in individuals with neurodegenerative disorders
according to new international sleep scoring criteria. J. Clin. Neurophysiol. 27,
296–302. doi: 10.1097/WNP.0b013e3181eaad4b
Kempfner, J., Jennum, P., Nikolic, M., Christensen, J. A. E., and Sorensen, H. B.
D. (2013). Sleep phenomena as an early biomarker for Parkinsonism. Conf.
Proc. IEEE Eng. Med. Biol. Soc. 2013, 5773–5776. doi: 10.1109/EMBC.2013.
6610863
Koch, H., Christensen, J. A. E., Frandsen, R., Arvastson, L., Christensen, S. R.,
Jennum, P. J., et al. (2014). Automatic sleep classification using a data-driven
topic model reveals latent sleep states. J. Neurosci. Methods 235, 130–137. doi:
10.1016/j.jneumeth.2014.07.002
Ktonas, P. Y., Golemati, S., Xanthopoulos, P., Sakkalis, V., Ortigueira, M. D.,
Tsekou, H., et al. (2009). Time-frequency analysis methods to quantify the
time-varying microstructure of sleep EEG spindles: possibility for dementia
biomarkers? J. Neurosci. Methods 185, 133–142. doi: 10.1016/j.jneumeth.2009.
09.001
Landis, J. R., and Koch, G. G. (1977). The measurement of observer
agreement for categorical data. Biometrics 33, 159–174. doi: 10.2307/
2529310
Latreille, V., Carrier, J., Lafortune, M., Postuma, R. B., Bertrand, J.-A.,
Panisset, M., et al. (2015). Sleep spindles in Parkinson’s disease may
predict the development of dementia. Neurobiol. Aging 36, 1083–1090. doi:
10.1016/j.neurobiolaging.2014.09.009
Latreille, V., Carrier, J., Montplaisir, J., Lafortune, M., and Gagnon, J.-F. (2011).
Non-rapid eye movement sleep characteristics in idiopathic REM sleep
behavior disorder. J. Neurol. Sci. 310, 159–162. doi: 10.1016/j.jns.2011.06.022
Leiser, S. C., Dunlop, J., Bowlby, M. R., and Devilbiss, D. M. (2011).
Aligning strategies for using EEG as a surrogate biomarker: a review of
preclinical and clinical research. Biochem. Pharmacol. 81, 1408–1421. doi:
10.1016/j.bcp.2010.10.002
Margis, R., Schönwald, S. V., Carvalho, D. Z., Gerhardt, G. J. L., and Rieder, C.
R. M. (2015). NREM sleep alpha and sigma activity in Parkinson’s disease:
evidence for conflicting electrophysiological activity? Clin. Neurophysiol. 126,
951–958. doi: 10.1016/j.clinph.2014.07.034
Martin, N., Lafortune, M., Godbout, J., Barakat, M., Robillard, R., Poirier, G., et al.
(2013). Topography of age-related changes in sleep spindles. Neurobiol. Aging
34, 468–476. doi: 10.1016/j.neurobiolaging.2012.05.020
Micallef, J., Rey, M., Eusebio, A., Audebert, C., Rouby, F., Jouve, E., et al. (2009).
Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled
study of L-dopa, bromocriptine and pramipexole in healthy subjects. Br. J. Clin.
Pharmacol. 67, 333–340. doi: 10.1111/j.1365-2125.2008.03310.x
Micanovic, C., and Pal, S. (2014). The diagnostic utility of EEG in early-onset
dementia: a systematic review of the literature with narrative analysis. J. Neural
Transm. 121, 59–69. doi: 10.1007/s00702-013-1070-5
Myslobodsky, M., Mintz, M., Ben-Mayor, V., and Radwan, H. (1982). Unilateral
dopamine deficit and lateral EEG assymmetry: sleep abnormalities in hemi-
Parkinson’s patients. Electroencephalogr. Clin. Neurophysiol. 54, 227–231. doi:
10.1016/0013-4694(82)90164-X
Nguyen, L., Bradshaw, J. L., Stout, J. C., Croft, R. J., and Georgiou-Karistianis, N.
(2010). Electrophysiological measures as potential biomarkers in Huntington’s
disease: review and future directions. Brain Res. Rev. 64, 177–194. doi:
10.1016/j.brainresrev.2010.03.004
Nicolas, A., Petit, D., Rompré, S., and Montplaisir, J. (2001). Sleep spindle
characteristics in healthy subjects of different age groups. Clin. Neurophysiol.
112, 521–527. doi: 10.1016/S1388-2457(00)00556-3
Petit, D., Gagnon, J.-F., Fantini, M. L., Ferini-Strambi, L., and Montplaisir,
J. (2004). Sleep and quantitative EEG in neurodegenerative disorders.
J. Psychosom. Res. 56, 487–496. doi: 10.1016/j.jpsychores.2004.02.001
Postuma, R. B., Gagnon, J. F., Rompré, S., and Montplaisir, J. Y. (2010). Severity of
REM atonia loss in idiopathic REM sleep behavior disorder predicts Parkinson
disease. Neurology 74, 239–244. doi: 10.1212/WNL.0b013e3181ca0166
Primavera, A., and Novello, P. (1992). Quantitative electroencephalography
in Parkinson’s disease, dementia, depression and normal aging.
Neuropsychobiology 25, 102–105. doi: 10.1159/000118817
Puca, F., Bricolo, A., and Turella, G. (1973). Effect of L-DOPA or amantadine
therapy on sleep spindles in parkinsonism. Electroencephalogr. Clin.
Neurophysiol. 35, 327–330. doi: 10.1016/0013-4694(73)90245-9
Frontiers in Human Neuroscience | www.frontiersin.org 12 May 2015 | Volume 9 | Article 233
Christensen et al. Spindle alterations in PD patients
Rauchs, G., Schabus, M., Parapatics, S., Bertran, F., Clochon, P., Hot, P.,
et al. (2008). Is there a link between sleep changes and memory in
Alzheimer’s disease?Neuroreport 19, 1159–1162. doi: 10.1097/WNR.0b013e328
30867c4
Rodrigues Brazète, J., Montplaisir, J., Petit, D., Postuma, R. B., Bertrand, J.-
A., Génier Marchand, D., et al. (2013). Electroencephalogram slowing in
rapid eye movement sleep behavior disorder is associated with mild cognitive
impairment. Sleep Med. 14, 1059–1063. doi: 10.1016/j.sleep.2013.06.013
Roth, C., Jeanmonod, D.,Magnin,M.,Morel, A., andAchermann, P. (2000). Effects
of medial thalamotomy and pallido-thalamic tractotomy on sleep and waking
EEG in pain and parkinsonian patients. Clin. Neurophysiol. 111, 1266–1275.
doi: 10.1016/S1388-2457(00)00295-9
Salawu, F., Danburam, A., and Olokoba, A. (2010). Non-motor symptoms of
Parkinson’s disease: diagnosis andmanagement.Niger. J. Med. 19, 126–131. doi:
10.4314/njm.v19i2.56496
Schabus, M., Hödlmoser, K., Gruber, G., Sauter, C., Anderer, P., Klösch, G., et al.
(2006). Sleep spindle-related activity in the human EEG and its relation to
general cognitive and learning abilities. Eur. J. Neurosci. 23, 1738–1746. doi:
10.1111/j.1460-9568.2006.04694.x
Schenck, C. H., Boeve, B. F., and Mahowald, M. W. (2013a). Delayed emergence
of a parkinsonian disorder or dementia in 81% of older men initially
diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-
year update on a previously reported series. Sleep Med. 14, 744–748. doi:
10.1016/j.sleep.2012.10.009
Schenck, C. H., Bundlie, S. R., and Mahowald, M. W. (1996). Delayed emergence
of a parkinsonian disorder in 38 % of 29 older men initially diagnosed with
idiopathic rapid eye movement sleep behavior disorder.Neurology 46, 388–393.
doi: 10.1212/WNL.46.2.388
Schenck, C. H., Montplaisir, J. Y., Frauscher, B., Hogl, B., Gagnon, J.-F., Postuma,
R., et al. (2013b). Rapid eye movement sleep behavior disorder: devising
controlled active treatment studies for symptomatic and neuroprotective
therapy–a consensus statement from the International Rapid Eye Movement
Sleep Behavior Disorder Study Group. Sleep Med. 14, 795–806. doi:
10.1016/j.sleep.2013.02.016
Sirakov, A., and Mezan, I. (1963). EEG findings in parkinsonism.
Electroencephalogr. Clin. Neurophysiol. 15, 321–322. doi: 10.1016/0013-
4694(63)90101-9
Soikkeli, R., Partanen, J., Soininen, H., Pääkkönen, A., and Sr. Riekkinen, P. (1991).
Slowing of EEG in Parkinson’s disease. Electroencephalogr. Clin. Neurophysiol.
79, 159–165. doi: 10.1016/0013-4694(91)90134-P
Sorensen, G. L., Kempfner, J., Zoetmulder, M., Sorensen, H. B. D., and Jennum,
P. (2012). Attenuated heart rate response in REM sleep behavior disorder and
Parkinson’s disease.Mov. Disord. 27, 888–894. doi: 10.1002/mds.25012
Sorensen, G. L., Mehlsen, J., and Jennum, P. (2013). Reduced sympathetic activity
in idiopathic rapid-eye-movement sleep behavior disorder andParkinson’s
disease. Auton. Neurosci. 179, 138–141. doi: 10.1016/j.autneu.2013.
08.067
Steriade, M., McCormick, D., and Sejnowski, T. (1993). Thalamocortical
oscillations in the sleeping and aroused brain. Science 262, 679–685. doi:
10.1126/science.8235588
Steriade, M., and Timofeev, I. (2003). Neuronal plasticity in thalamocortical
networks during sleep and waking oscillations. Neuron 37, 563–576. doi:
10.1016/S0896-6273(03)00065-5
Stevens, S., and Comella, C. L. (2013). “Rapid eye movement sleep behavior
disorder,” in Parkinson’s Disease and Nonmotor Dysfunction, 2nd Edn., eds R.
F. Pfeiffer and Bodis-Wollner (New York, NY: Humana Press Inc.), 257–265.
Wamsley, E. J., Tucker, M. A., Shinn, A. K., Ono, K. E., McKinley, S. K., Ely, A. V.,
et al. (2012). Reduced sleep spindles and spindle coherence in schizophrenia:
mechanisms of impaired memory consolidation? Biol. Psychiatry 71, 154–161.
doi: 10.1016/j.biopsych.2011.08.008
Warby, S. C., Wendt, S. L., Welinder, P., Munk, E. G. S., Carrillo, O., Sorensen,
H. B. D., et al. (2014). Sleep-spindle detection: crowdsourcing and evaluating
performance of experts, non-experts and automated methods.Nat. Methods 11,
385–392. doi: 10.1038/nmeth.2855
Wauquier, A. (1993). Aging and changes in phasic events during sleep. Physiol.
Behav. 54, 803–806. doi: 10.1016/0031-9384(93)90095-W
Wendt, S. L.,Welinder, P., Sorensen, H. B. D., Jennum, P. J., Peppard, P. E., Perona,
P., et al. (2014). Inter-expert and intra-expert reliability in sleep spindle scoring.
Clin. Neurophysiol. doi: 10.1016/j.clinph.2014.10.158. [Epub ahead of print].
Wermuth, L., Lassen, C. F., Himmerslev, L., Olsen, J., and Ritz, B. (2012).
Validation of hospital register-based diagnosis of Parkinson’s disease. Dan.
Med. J. 59:A4391.
Westerberg, C. E., Mander, B. A., Florczak, S. M., Weintraub, S., Mesulam, M.-
M., Zee, P. C., et al. (2012). Concurrent impairments in sleep and memory in
amnestic mild cognitive impairment. J. Int. Neuropsychol. Soc. 18, 490–500. doi:
10.1017/S135561771200001X
Conflict of Interest Statement: The Reviewer Veronique Latreille declares that,
despite being affiliated to the same institution as the author Simon C. Warby,
the review process was handled objectively and no conflict of interest exists. The
authors declare that the research was conducted in the absence of any commercial
or financial relationships that could be construed as a potential conflict of interest.
Copyright © 2015 Christensen, Nikolic, Warby, Koch, Zoetmulder, Frandsen,
Moghadam, Sorensen, Mignot and Jennum. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use,
distribution or reproduction in other forums is permitted, provided the original
author(s) or licensor are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Human Neuroscience | www.frontiersin.org 13 May 2015 | Volume 9 | Article 233
